BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 12759921)

  • 1. Genome-wide amplification and allelotyping of sporadic pituitary adenomas identify novel regions of genetic loss.
    Simpson DJ; Bicknell EJ; Buch HN; Cutty SJ; Clayton RN; Farrell WE
    Genes Chromosomes Cancer; 2003 Jul; 37(3):225-36. PubMed ID: 12759921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 13q deletion mapping in pituitary tumors: infrequent loss of the retinoblastoma susceptibility gene (RB1) locus despite loss of RB1 protein product in somatotrophinomas.
    Simpson DJ; Magnay J; Bicknell JE; Barkan AL; McNicol AM; Clayton RN; Farrell WE
    Cancer Res; 1999 Apr; 59(7):1562-6. PubMed ID: 10197629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of recurrence of nonfunctioning pituitary tumours by loss of heterozygosity analysis.
    Buch HN; Raskauskiene D; Bahar A; Bicknell EJ; Farrell WE; Clayton RN
    Clin Endocrinol (Oxf); 2004 Jul; 61(1):19-25. PubMed ID: 15212640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific loss of heterozygosity in multiple colorectal adenomas: toward an integrated molecular cytogenetic map II.
    Mao X; Hamoudi RA; Talbot IC; Baudis M
    Cancer Genet Cytogenet; 2006 May; 167(1):1-14. PubMed ID: 16682279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined genome-wide allelotyping and copy number analysis identify frequent genetic losses without copy number reduction in medulloblastoma.
    Langdon JA; Lamont JM; Scott DK; Dyer S; Prebble E; Bown N; Grundy RG; Ellison DW; Clifford SC
    Genes Chromosomes Cancer; 2006 Jan; 45(1):47-60. PubMed ID: 16149064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathogenesis of pituitary tumors.
    Farrell WE; Clayton RN
    Front Neuroendocrinol; 2000 Jul; 21(3):174-98. PubMed ID: 10882539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma.
    Wistuba II; Tang M; Maitra A; Alvarez H; Troncoso P; Pimentel F; Gazdar AF
    Cancer Res; 2001 May; 61(9):3795-800. PubMed ID: 11325854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.
    Tahara H; Smith AP; Gas RD; Cryns VL; Arnold A
    Cancer Res; 1996 Feb; 56(3):599-605. PubMed ID: 8564978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
    Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
    Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosome 9p deletions in invasive and noninvasive nonfunctional pituitary adenomas: the deleted region involves markers outside of the MTS1 and MTS2 genes.
    Farrell WE; Simpson DJ; Bicknell JE; Talbot AJ; Bates AS; Clayton RN
    Cancer Res; 1997 Jul; 57(13):2703-9. PubMed ID: 9205080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic mapping and DNA sequence-based analysis of deleted regions on chromosome 16 involved in progression of bladder cancer from occult preneoplastic conditions to invasive disease.
    Yoon DS; Li L; Zhang RD; Kram A; Ro JY; Johnston D; Grossman HB; Scherer S; Czerniak B
    Oncogene; 2001 Aug; 20(36):5005-14. PubMed ID: 11526485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker.
    Bates AS; Farrell WE; Bicknell EJ; McNicol AM; Talbot AJ; Broome JC; Perrett CW; Thakker RV; Clayton RN
    J Clin Endocrinol Metab; 1997 Mar; 82(3):818-24. PubMed ID: 9062489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors.
    Mathew S; Murty VV; Bosl GJ; Chaganti RS
    Cancer Res; 1994 Dec; 54(23):6265-9. PubMed ID: 7954476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis.
    Shen CY; Yu JC; Lo YL; Kuo CH; Yue CT; Jou YS; Huang CS; Lung JC; Wu CW
    Cancer Res; 2000 Jul; 60(14):3884-92. PubMed ID: 10919664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-resolution 19p13.2-13.3 allelotyping of breast carcinomas demonstrates frequent loss of heterozygosity.
    Yang TL; Su YR; Huang CS; Yu JC; Lo YL; Wu PE; Shen CY
    Genes Chromosomes Cancer; 2004 Nov; 41(3):250-6. PubMed ID: 15334548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningiomas: analysis of loss of heterozygosity on chromosome 10 in tumor progression and the delineation of four regions of chromosomal deletion in common with other cancers.
    Mihaila D; Gutiérrez JA; Rosenblum ML; Newsham IF; Bögler O; Rempel SA;
    Clin Cancer Res; 2003 Oct; 9(12):4435-42. PubMed ID: 14555516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.
    Clayton RN; Pfeifer M; Atkinson AB; Belchetz P; Wass JA; Kyrodimou E; Vanderpump M; Simpson D; Bicknell J; Farrell WE
    Clin Cancer Res; 2000 Oct; 6(10):3973-82. PubMed ID: 11051246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the MEN1 gene in sporadic pituitary adenomas.
    Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
    J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.